Review of the Interaction Between Body Composition and Clinical Outcomes in Metastatic Renal Cell Cancer Treated With Targeted Therapies

Review of the Interaction Between Body Composition and Clinical Outcomes in Metastatic Renal Cell Cancer Treated With Targeted Therapies

<p>Treatment of metastatic renal cell cancer (mRCC) currently focuses on inhibition of the vascular endothelial growth factor pathway and the mammalian target of rapamycin (mTOR) pathway. Obesity confers a higher risk of RCC. However, the influence of obesity on clinical outcomes in mRCC in th...

Full description

Bibliographic Details
Main Authors: Steven M Yip, Daniel Y. C. Heng, Patricia A. Tang
Format: Article
Language:English
Published: Codon Publications 2016-03-01
Series:Journal of Kidney Cancer and VHL
Subjects:
adiposity
body composition
obesity
renal cell carcinoma
sarcopenia
targeted therapy
toxicity
Online Access:http://jkcvhl.com/index.php/jkcvhl/article/view/45

Internet

http://jkcvhl.com/index.php/jkcvhl/article/view/45

Similar Items